Edap Tms S.A. (NASDAQ:EDAP – Get Free Report) saw a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 101,300 shares, a decline of 5.1% from the May 15th total of 106,800 shares. Based on an average trading volume of 37,300 shares, the short-interest ratio is currently 2.7 days.
Edap Tms Stock Down 0.9 %
EDAP opened at $5.33 on Tuesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.62 and a quick ratio of 2.00. The firm has a 50 day simple moving average of $6.57 and a 200 day simple moving average of $6.36. Edap Tms has a fifty-two week low of $3.60 and a fifty-two week high of $9.53.
Edap Tms (NASDAQ:EDAP – Get Free Report) last posted its quarterly earnings results on Thursday, May 16th. The medical equipment provider reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). The business had revenue of $16.13 million for the quarter, compared to the consensus estimate of $16.22 million. Edap Tms had a negative return on equity of 31.44% and a negative net margin of 30.12%. Equities research analysts anticipate that Edap Tms will post -0.51 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
View Our Latest Report on EDAP
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the company. Rock Springs Capital Management LP grew its holdings in Edap Tms by 14.6% during the third quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock valued at $9,547,000 after purchasing an additional 173,700 shares during the period. Virtu Financial LLC bought a new stake in shares of Edap Tms during the first quarter worth $82,000. Roubaix Capital LLC bought a new stake in shares of Edap Tms during the first quarter worth $169,000. Finally, Miracle Mile Advisors LLC bought a new stake in shares of Edap Tms during the first quarter worth $136,000. Institutional investors and hedge funds own 62.74% of the company’s stock.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
See Also
- Five stocks we like better than Edap Tms
- How to invest in blue chip stocks
- CAVA’s Per-Restaurant Stock Value Outshines Chipotle’s
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- The Most Shorted Stocks in June: Hold, Short, or Squeeze?
- 3 REITs to Buy and Hold for the Long Term
- Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.